In November 2023, the UK Foreign, Commonwealth & Development Affairs (FCDO) released a White Paper on International Development. STOPAIDS’ analysis of the white paper reveals noteworthy elements such as the commitment to digital transformation, emphasis on equal partnership and local production, and recognition of the critical role played by the World Health Organisation. Despite these … Continued
This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued
Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued
STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued
This report follows the inquiry conducted by the APPG on HIV, STOPAIDS and Frontline AIDS on the impact of the ODA cuts on the HIV response. Through exploring case studies of UK Aid- funded multilateral, bilateral and research projects, it analyses how crucial organisations, people living with HIV and the HIV response are being affected … Continued
https://stopaids.org.uk/wp-content/uploads/2020/04/Equitable-access-to-COVID-19-diagnostics-vaccines-and-treatments-1-1.pdf